{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:48:53Z","timestamp":1790790533345,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00672","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:33:31Z","timestamp":1568367211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers"],"prefix":"10.3389","volume":"10","author":[{"given":"Nadia R. P. W.","family":"Hutten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Dolder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim P. C.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"B1","volume-title":"The psychedelic explorer\u2019s guide: Safe, therapeutic, and sacred journeys","author":"Fadiman","year":"2011"},{"key":"B2","unstructured":"microdosing2018"},{"key":"B3","unstructured":"GlatterR\n          ForbesLSD microdosing: the new job enhancer in Silicon Valley2015"},{"key":"B4","unstructured":"SolonO\n          WIREDUnder pressure, Silicon Valley workers turn to LSD microdosing2016"},{"key":"B5","unstructured":"DeanJ\n          Micro-dosing: The Drug Habit Your Boss Is Gonna Love2017"},{"key":"B6","unstructured":"FadimanJ\n          Psychedelic PressMicrodose Research: Without approvals, control groups, double-blinds, staff or funding by Dr James Fadiman2017"},{"key":"B7","unstructured":"Reddit\n          r\/microdosing2018"},{"key":"B8","unstructured":"TomaszewskiM\n          LSD to GTD: Can You Improve at Work by Microdosing LSD?2018"},{"key":"B9","first-page":"1","article-title":"Microdosing Psychedelics: more questions than answers? An overview and suggestions for future research","volume-title":"J Psychopharm","author":"Kuypers","year":"2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","article-title":"Motives and side-effects of microdosing with psychedelics among users","volume":"22","author":"Hutten","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1455072517753339","article-title":"Powerful substances in tiny amounts: an interview study of psychedelic microdosing","volume":"35","author":"Johnstad","year":"2018","journal-title":"Nord Stud Alcohol Dr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.04.013","article-title":"Narrative identity, rationality, and microdosing classic psychedelics","volume":"70","author":"Webb","year":"2019","journal-title":"Int J Drug Policy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J Nerv Ment Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of \u00b1 3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J Psychopharm"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of lysergic acid diethylamide as an analgesic agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesth Analg"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2016_459","article-title":"Phenomenology, structure, and dynamic of psychedelic states","volume-title":"Behavioral Neurobiology of Psychedelic Drugs","author":"Preller","year":"2016"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.paid.2017.06.004","article-title":"Neuroticism is associated with challenging experiences with psilocybin mushrooms","volume":"117","author":"Barrett","year":"2017","journal-title":"Pers Individ Dif"},{"key":"B21","unstructured":"GDS2019 Key Findings Report\/Executive Summary\n            WinstockAR\n          2019"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00268","article-title":"The co-occurrence of autism and attention deficit hyperactivity disorder in children\u2013what do we know","volume":"8","author":"Leitner","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/children4080062","article-title":"DSM-5 changes in attention deficit hyperactivity disorder and autism spectrum disorder: implications for comorbid sleep issues","volume":"4","author":"Ramtekkar","year":"2017","journal-title":"Children"},{"key":"B24","article-title":"What is the difference between autism and ADHD","volume-title":"Medical News Today","author":"Leonard","year":"2019"},{"key":"B25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"B27","unstructured":"Reddit\n          Anyone with pure obsessive ocd microdosing?2019"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharm"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901208010180","article-title":"What did we learn from research on comorbidity in psychiatry? Advantages and limitations in the forthcoming DSM-V era","volume":"8","author":"Dell\u2019Osso","year":"2012","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2006.12.009","article-title":"Testing the tripartite model in young adolescents: Is hyperarousal specific for anxiety and not depression","volume":"102","author":"Greaves-Lord","year":"2007","journal-title":"J Affect Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpsycho.2008.07.001","article-title":"EEG in adults with attention-deficit\/hyperactivity disorder","volume":"70","author":"Clarke","year":"2008","journal-title":"Int J Psychophysiol"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:33:34Z","timestamp":1568367214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":34,"alternative-id":["10.3389\/fpsyt.2019.00672"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00672","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"article-number":"672"}}